Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001902368-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | May 7, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
79,485
Total Value
$1,463,085.55
P&L
+inf% (+$468,435.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | May 4, 2026 | Exercise/Conversion | 20,000 | $22.40 | $448,000.00 | 131,473 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | May 4, 2026 | Sale | 20,000 | $45.00 | $900,000.00 | 111,473 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | May 4, 2026 | Exercise/Conversion | 4,250 | $0.00 | $0.00 | 115,723 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | May 5, 2026 | Sale | 2,174 | $46.65 | $101,417.10 | 113,549 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | May 6, 2026 | Sale | 311 | $43.95 | $13,668.45 | 113,238 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Employee stock option (right to buy) | Derivative | May 4, 2026 | Exercise/Conversion | 20,000 | $0.00 | $0.00 | 34,500 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Performance-based restricted stock units | Derivative | May 4, 2026 | Grant/Award | 8,500 | $0.00 | $0.00 | 8,500 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Performance-based restricted stock units | Derivative | May 4, 2026 | Exercise/Conversion | 4,250 | $0.00 | $0.00 | 4,250 | Direct | โ | View Details |